ArticleThe Lancet regional health. Europe2025
COVID-19 infection and severity among childhood cancer survivors in Denmark and Sweden: a register-based cohort study with matched population and sibling comparisons.
Article in The Lancet regional health. Europe, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Survey on COVID-19 Vaccination among Pediatric Cancer Patients and Their Parents: A Single-Center Study from Korea.Infection & chemotherapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: During the COVID-19 pandemic, vulnerable groups faced a higher risk of severe COVID-19 outcomes. The effect of the pandemic on adult childhood cancer survivors is a significant public health concern but not sufficiently understood. We aimed to assess whether adult childhood cancer survivors had a higher risk of severe COVID-19 and registered COVID-19 infections compared to the general population. Methods: This Nordic register-based cohort study included 5-year childhood cancer survivors diagnosed before age 20 years in Denmark and Sweden, two countries with very different pandemic responses. As comparisons, we randomly selected individuals from the general population, matched on year of birth, sex, and country, and identified all siblings of the survivors. All individuals at least 20 years old and alive on January 1, 2020, were followed until December 31, 2022. We plotted the cumulative hazard rates of severe COVID-19 and registered COVID-19 infection and fitted Cox proportional hazards models estimating adjusted hazard ratios (aHR) with 95% confidence intervals (95% CI). Findings: The cohort included 13,659 cancer survivors, 58,803 matched comparisons, and 17,531 siblings. Childhood cancer survivors had a lower risk of registered COVID-19 infection (aHR = 0·91; 95% CI = 0·89-0·94) compared to their comparisons but a higher risk of severe COVID-19 (aHR = 1·58; 95% CI = 1·25-1·98). The latter was particularly evident during periods of widespread viral transmission, as reflected in differences between Denmark and Sweden. Interpretation: These findings underscore the heightened vulnerability of childhood cancer survivors, even many years after their cancer diagnosis, and emphasize the need for closer monitoring and tailored interventions to safeguard this population during future health crises. Funding: Danish and Swedish Childhood Cancer Foundation, Danish National Research Centre for Childhood Cancer, Swedish Research Council, and NordForsk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.